E-mail a Wiley Online Library Link

Tait D. Shanafelt, Timothy G. Call, Clive S. Zent, Jose F. Leis, Betsy LaPlant, Deborah A. Bowen, Michelle Roos, Kristina Laumann, Asish K. Ghosh, Connie Lesnick, Mao-Jung Lee, Chung S. Yang, Diane F. Jelinek, Charles Erlichman and Neil E. Kay Phase 2 trial of daily, oral polyphenon E in patients with asymptomatic, Rai stage 0 to II chronic lymphocytic leukemia Cancer 119

Version of Record online: 3 JUL 2012 | DOI: 10.1002/cncr.27719

In this phase 2 trial, daily oral use of the green tea extract epigallocatechin gallate in the Polyphenon E preparation was found to be well tolerated by patients with chronic lymphocytic leukemia. Durable declines in the absolute lymphocyte count and/or lymphadenopathy were observed in the majority of patients.

Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf

Required = Required Field